Abiopharma

General Announcement: May 2026 Operating Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Changes in Interest of Director

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Changes in Interest of Director

JCDecaux : Déclaration des transactions sur actions propres

JCDecaux : Disclosure of transactions in own shares

General Announcement: Next Day Disclosure Return

NEURONES: Declaration of transactions on treasury shares (June 8 to 12, 2026)

NEURONES : Déclaration des transactions sur actions propres (période du 8 au 12 juin 2026)

Ultomiris granted Priority Review in the US as treatment for adults with immunoglobulin A nephropathy

Warrants - Change of Terms: Notice of Change of Terms